NEW YORK (360Dx) – VolitionRx today priced a public offering of 3.5 million shares of its common stock at $2.40 per share.

Gross proceeds from the offering, expected to close on or about March 13, are expected to be about $8.4 million. The company has also granted the offering's underwriters a 30-day option to cover any overallotments. Oppenheimer is the sole book-running manager for the offering. National Securities is the co-manager.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.